Pharmaron Beijing Co., Ltd. (SHE:300759)
30.96
+0.09 (0.29%)
Oct 22, 2025, 3:04 PM CST
Pharmaron Beijing Revenue
Pharmaron Beijing had revenue of 3.34B CNY in the quarter ending June 30, 2025, with 13.92% growth. This brings the company's revenue in the last twelve months to 13.11B, up 14.00% year-over-year. In the year 2024, Pharmaron Beijing had annual revenue of 12.28B with 6.39% growth.
Revenue (ttm)
13.11B
Revenue Growth
+14.00%
P/S Ratio
3.99
Revenue / Employee
572.39K
Employees
21,370
Market Cap
52.26B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 12.28B | 737.78M | 6.39% |
Dec 31, 2023 | 11.54B | 1.27B | 12.39% |
Jan 1, 2023 | 10.27B | 2.82B | 37.92% |
Dec 31, 2021 | 7.44B | 2.31B | 45.00% |
Dec 31, 2020 | 5.13B | 1.38B | 36.64% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Huadong Medicine | 42.62B |
WuXi AppTec | 41.90B |
Yunnan Baiyao Group Co.,Ltd | 40.84B |
Shanghai Fosun Pharmaceutical (Group) | 40.12B |
Shenzhen Mindray Bio-Medical Electronics | 32.94B |
Jiangsu Hengrui Medicine | 30.15B |
Zhejiang NHU Company | 22.87B |
Aier Eye Hospital Group | 21.94B |